Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Other Operating Expenses (2016 - 2025)

Abeona Therapeutics (ABEO) has 14 years of Other Operating Expenses data on record, last reported at $488000.0 in Q3 2025.

  • For Q3 2025, Other Operating Expenses changed N/A year-over-year to $488000.0; the TTM value through Sep 2025 reached $588000.0, changed N/A, while the annual FY2023 figure was $540000.0, 91.16% down from the prior year.
  • Other Operating Expenses reached $488000.0 in Q3 2025 per ABEO's latest filing, up from $100000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $32.5 million in Q4 2021 and bottomed at -$1.1 million in Q2 2022.
  • Average Other Operating Expenses over 4 years is $2.8 million, with a median of $65000.0 recorded in 2023.
  • Peak YoY movement for Other Operating Expenses: crashed 6266.67% in 2022, then skyrocketed 6816.67% in 2023.
  • A 4-year view of Other Operating Expenses shows it stood at $32.5 million in 2021, then plummeted by 96.77% to $1.0 million in 2022, then crashed by 97.14% to $30000.0 in 2023, then skyrocketed by 1526.67% to $488000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $488000.0 in Q3 2025, $100000.0 in Q2 2025, and $30000.0 in Q3 2023.